Background and aims: Published guidelines for the management of adult patients with severe traumatic brain injury prescribe the maintenance of a general threshold of cerebral perfusion pressure (CPP) of 60 mm Hg during intensive care monitoring of arterial blood pressure (ABP) and intracranial pressure (ICP). 1 This threshold value of CPP is near the critical threshold for ischemia, the lower limit of cerebrovascular autoregulation, which is generally thought to be between 50 to 60 mm Hg. 2 These guidelines point out the need for the development of methods that individualize patient CPP management and minimize secondary ischemic complications associated with traumatic brain injury. 1 We have developed a laboratory method to determine model-derived assessments of cerebrovascular resistance (mCVR) and cerebral blood flow (mCBF) from cerebrovascular pressure transmission, the dynamic relationship between ABP and ICP. 3 The aim of this twofold study is to:
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(1) evaluate relative changes in the model-derived parameters of mCVR and mCBF with corresponding changes in the pial arteriolar vascular parameters of pial arteriolar resistance (PAR) and relative pial arteriolar blood flow (rPABF); and (2) examine the efficacy of the proposed modeling methodology for continuous assessment of the state of cerebrovascular regulation by evaluating relative changes in the model-derived parameters, mCVR and mCBF, in relation to changes of CPP induced by pressor challenge prior to and following fluid percussion brain injury.
Methods: Changes of arterial blood pressure (ABP), intracranial pressure (ICP), pial arteriolar resistance (PAR) and relative blood flow (rPABF) induced by acute pressor challenge (norepinephrine (1 uk/kg/ min)) were evaluated in both uninjured and fluid percussion brain injured piglets (N = 6) equipped with cranial windows. Assessments of modelderived cerebrovascular resistance (mCVR) and cerebral blood flow (mCBF) were obtained by a computational modeling method of cerebrovascular pressure transmission for each challenge.
Results: Consistent with functional autoregulation of the uninjured cerebrovascular circulation, hypertensive challenge resulted in a significant increase of PAR and mCVR; whereas, both rPABF and mCBF remained constant. For all injured piglets, hypertensive challenge resulted in a significant decrease of PAR and mCVR consistent with impaired autoregulation. Hypertensive challenge also significantly increased both rPABF, and mCBF with increased CPP with correlation values of (r = 0.96, P < 0.01) and (r = 0.97, Pp0.01) respectively.
Conclusions: Assessment of model-derived cerebrovascular resistance and cerebral blood flow with changes of CPP may provide a means to continuously monitor the state of cerebrovascular regulation and cerebral perfusion.
regulation during intensive care monitoring of arterial blood pressure (ABP) and intracranial pressure (ICP). 1 The lower limits of regulation for pediatric patients are age-dependent 2 and generally unknown. To prevent either excessive or insufficient perfusion during management, a method designed to continuously evaluate cerebral blood flow (CBF) and cerebrovascular resistance (CVR) of each patient is needed. The aim of this study is to validate a computational method based on a biomechanical model of the dynamic relationship between ABP and ICP. This method is designed to continuously assess to model derived parameters of cerebral blood flow (mCBF) and cerebrovascular resistance (mCVR). Comparisons between experimental and model derived assessments of CBF and CVR were made to examine the validity of the proposed modeling methodology. Methods: ABP, ICP, CPP, CBF by H 2 clearance, and pial arteriolar diameter (PAD) were measured in piglets equipped with cranial windows during normocapnia (N = 6) and permissive hypercapnia (N = 4). Corresponding mCVR and mCBF were calculated. Experimental CVR was computed as CPP/ CBF and pial arterial resistance (PAR) was derived from PAD. Grand mean parameter values ( ± s.d.) were derived for each experimental condition.
Results: A summary of the comparisons between experimentally derived values of CBF, CVR, and PAR and the model-derived values of mCBF and mCVR is given in Table 1 . Experimental and model-derived values of CBF and CVR were not significantly different.
Objective: Preterm infants are at significant risk of brain injury, in part due to their limited ability to regulate cerebral blood flow (CBF). A continuous monitor of CBF at the bedside could therefore be a valuable supplement for gathering information about a patient's condition and for guiding treatment.
In this study, diffuse correlation spectroscopy (DCS), a continuous and non-invasive optical technique to measure blood flow, and transcranial Doppler ultrasound (TCD) were employed to monitor the cerebral hemodynamics of 4 preterm neonates during a 0 to 121 postural change on 9 different days. Methods: The DCS instrument consists of a 785 nm source laser, a single mode detector fiber located on the tissue surface 1.5 cm from the source, and detection electronics to measure the light intensity autocorrelation function. Variations in the decay time of the autocorrelation function, which we refer to as the blood flow index (BFI) are related to blood flow in the tissue. 1 BFI was recorded on the forehead .5 ( ± 0.9) a 66.9 ( ± 3.2) a 34.5 ( ± 0.4) 34.7 ( ± 1.8) 1.9 ( ± 0.1) a 1.9 ( ± 0.2) a 4968.0 ( ± 126.7)
a Denotes a significant degree of difference between mean values of normocapnic and permissive hypercapnic groups at P < 0.01.
of each preterm infant at 7 Hz for 5 mins at each head-of-bed angle (HOB) adjustment from 0 to 121 and was repeated 3 times. For TCD, measurements of peak systolic, end diastolic, and mean velocities (PSV, EDV, and MV respectively) were obtained on the middle cerebral artery. Three data points were taken at each HOB angle before the bed was repositioned, and the HOB angle was elevated twice. DCS and TCD measurements were not taken at the same time. Results: Figure 1 shows the relationship between baseline PSV and BFI for TCD and DCS data taken on the same day from the same patient. A significant correlation (P < 0.05) between PSV and BFI, as well as between MV and BFI, was discovered. Similar correlations were not found with BFI and EDV.
Both techniques showed no significant population averaged hemodynamic changes during HOB elevation as compared to HOB flat. In addition, no population averaged correlations between rCBF and relative ultrasound parameters were found (rCBF and rPSV, r s = 0.1, P > 0.05; rCBF and rEDV, r s = 0.17, P > 0.05; rCBF and rMV, r s = 0.1, P > 0.05).
Conclusions:
In summary, we have demonstrated the feasibility of DCS to continuously monitor changes in CBF in very low birthweight preterm infants. We also showed with DCS that when posed with a small HOB challenge, the infants maintained a constant CBF. This result was corroborated by findings from TCD measurements. Methods: Six patients with traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), or ischemic stroke were included in a validation study of diffuse correlation spectroscopy (DCS) against portable xenon-CT. CBF was measured continuously throughout two CT-scans: a baseline scan and a scan after pressor administration. Regions-of-interest under the DCS probes (placed bilaterally on the forehead) were drawn on the xenon-CT CBF maps, and CBF values were compared to values from DCS. Eleven TBI/SAH patients were recruited under a separate protocol to test DCS-CBF response to head-of-bed (HOB) elevation changes. DCS measured frontal cortical CBF while HOB position changed from 301 to supine, each for 5 mins. Results were compared against cerebral perfusion pressure (CPP) to assess cerebral autoregulation. Damaged autoregulation was defined as lack of correlation between CPP and CBF (P > 0.05).
Results: Relative CBF measurements from DCS and xenon-CT comparing baseline and post-intervention values showed good correlation (R = 0.72, P = 0.02).
Bland-Altman analysis comparing the two methods also showed good agreement. When HOB went from 301 to supine, CBF responses were highly variable both among patients as well as between hemispheres in a given patient. Figure below shows a CBF timeseries with this type of discrepancy, in a 45-year-old male with subarachnoid hemorrhage from anterior communicating artery-and left anterior choroidal artery-origin aneurysms. Autoregulation is often damaged by neurotraumatic events, and the correlation (P = 0.03) between this patient's left hemisphere CBF and CPP may be interpreted as damaged autoregulation on that side. As a contrast, right hemisphere CBF did not correlate with CPP (P = 0.29).
Averaged over the entire population, we saw a insignificant CBF decrease (À1.1% + À7.8%) with head flat, but found that individual responses did significantly change from baseline CBF (P < 0.05).
We have validated DCS against Xenon-CT as a measure of local, microvascular CBF. We have also observed damaged cerebral autoregulation in patients after severe head injury which was confirmed by a large correlation between CBF and CPP during a simple intervention. Our results demonstrate the potential for DCS to provide continuous, noninvasive bedside monitoring of CBF for the purpose of CBF management and individualized care. Objectives: Stem cell transplantation represents a promising experimental therapeutic avenue for central nervous system disorders. Before these therapies can come to fruition, however, in depth studies must be conducted to assess stem cell survival and biodistribution, especially in developing minimally invasive intravascular delivery techniques.
A novel multimodal approach to track neural progenitor cells in vivo
In the present study, we have designed a multimodality approach with which intravascular transplants can be studied for their biodistribution and survival. We have created a mouse neural progenitor cell line harboring a triple-fusion reporter gene encoding a luciferase, red fluorescent protein, and thymidine kinase PET reporter gene. To combine high sensitivity and spatial resolution, we have also included SPIO labeling for MR imaging to create a clinically applicable system to monitor neural stem cells after transplantation. Methods: C17.2 mouse neural progenitor cells were transduced by a Lentivirus harboring a tri-fusion reporter gene containing a synthetic Renilla lucifer-ase, monomeric RFP, and a truncated version of sr39 thymidine kinase (TK). Cells were also transfected with SPIO particles. Following transduction, RFP positive cells were selected using FACS.
Cells were analyzed for TK and Luciferase activity 48 h after FACS. Negative controls for both assays were performed using the parental C17.2 cells.
Adult nude mice were injected with either FACS isolated C17.2 cells positive for the triple-fusion reporter gene or parental C17.2 neural progenitor cells. 5 Â 10 5 FACS-sorted or wild-type cells were transplanted into the right or left striatum, respectively. Control injections of the respective cells were also performed subcutaneously into the shoulders.
In vivo bioluminescence imaging and T2*-weighted MRI was performed 3 days following transplantation. FHBG-PET imaging was also performed. Results: FACS analysis confirmed the presence of RFP, and thus the triple-fusion reporter gene in the C17.2 mouse neural progenitor cell line. In vitro assays also demonstrated luciferase and thymidine kinase activity in the RFP sorted cell line. Wild type cells did not exhibit any thymidine kinase and luciferase activity.
The in vivo data validated the activity of the triplefusion reporter gene after transplant, both in subcutaneous and intracerebral locations. Figure 1 demonstrates specific luciferase signal emission from the bolus of transduced cells from the shoulder, as well as the brain after intracerebral transplantation. Wild type cells transplanted on the contralateral shoulder and striatum did not emit any signal above background levels. PET confirmed the presence of the transduced cells and activity of the triple-fusion gene in vivo. SPIO transfection resulted in a typical susceptibility artifact on T2 and T2* weighted MRI. Conclusions: We describe a novel method for tracking cells after transplant. With this approach we obtain high spatial resolution from MRI and high sensitivity with PET. This method will enable studies of biodistribution and cell migration in both short and long term studies of CNS disorders. 
